One of the Listed Companies, The IBN SINA Pharmaceutical PLC has recommended 60% cash Dividend to its investors for the Financial Year ending June 30, 2023.
This source is known from DSE.
The Company has reported Consolidated EPS of Tk 19.38 paisa, and Consolidated NAV per share of Tk. 96.68, for the year ended June 30, 2023, as against Consolidated EPS of Tk 19.39 paisa same period last year.
The Annual General Meeting (AGM) of the company will be held on September 21 through the digital platform. The record date for this has been fixed at October 22.
Share this
